Respiratory and Critical Care Medicine Department (Pulmonary Disease Department)

【Department Establishment History】 The Department of Respiratory and Critical Care Medicine (Department of Pulmonary Diseases) of Shenzhen Traditional Chinese Medicine Hospital is a comprehensive department integrating medical care, teaching and scientific research. Established in 1992, the department upholds the hospital motto “Sincere Unity, Inheritance and Innovation”, adheres to the development principles of giving equal emphasis to traditional Chinese medicine and Western medicine, highlighting the characteristics of traditional Chinese medicine, combining internal and external therapies, and integrating medical care and prevention. After years of discipline development, it has grown into a respiratory disease specialty with strong technical capabilities, distinctive traditional Chinese medicine characteristics, significant clinical efficacy and advanced diagnostic and treatment equipment. 【Department Honors】 It is currently a key traditional Chinese medicine specialty of Guangdong Province, a key traditional Chinese medicine specialty of Shenzhen, a national PCCM department standardized-construction Level III hospital compliance unit, a national PCCM respiratory rehabilitation single-discipline training base, the chairing institution of the Pulmonary Disease Professional Committee of the Shenzhen Association of Chinese Medicine, a pulmonary rehabilitation training base for integrated traditional Chinese and Western medicine of the Guangdong Primary Medical and Health Care Association, and the Shenzhen Traditional Chinese Medicine Internal Medicine Medical Quality Control Center. It has one renowned traditional Chinese medicine physician each at the provincial and municipal levels, three provincial- and municipal-level renowned traditional Chinese medicine physician apprenticeship mentors, three doctoral supervisors and six master’s supervisors. Several doctors in the department have received titles including “Shenzhen Outstanding Physician”, “Anti-Epidemic Warrior”, “Outstanding Traditional Chinese Medicine Talent of the Pengcheng Qihuang Project” and “Shenzhen Health and Medical Elite Talent”. The discipline leader, Deputy Hospital Director Chen Sheng, is a Pengcheng Xinglin Leading Talent and an Xinglin Famous Doctor of Guangzhou University of Chinese Medicine (the only one in Shenzhen), serves as leader of the Shenzhen Expert Group for the Traditional Chinese Medicine Prevention and Treatment of Novel Coronavirus Infection, vice president of the Respiratory Branch of the World Federation of Chinese Medicine Societies, and deputy chair of the Respiratory Branch of the Guangdong Society of Chinese Materia Medica. 【Department Leadership】 Chief Physicians Gao Xue, Qu Jinglai and Chen Sheng successively served as department directors and made major contributions to the department’s development. Since 2023, Chief Physician Xie Wei has served as the person in charge of the department. 【Scope of Diagnosis and Treatment】 The department carries out integrated traditional Chinese and Western medicine diagnosis and treatment, scientific research and teaching for respiratory diseases including lung cancer, pulmonary nodules, chronic obstructive pulmonary disease, bronchial asthma, pulmonary interstitial fibrosis, pneumonia, bronchiectasis, bronchitis and sleep apnea syndrome. 【Department Operations】 It currently has 2 wards, 66 open beds and a medical and nursing team of more than 40 people. It has a respiratory endoscopy center, pulmonary function room and comprehensive traditional Chinese medicine treatment room, and is equipped with advanced devices including electronic bronchoscopes and endobronchial ultrasound bronchoscopes. It has more than 80,000 outpatient visits and more than 1,800 discharges annually. Specialty outpatient clinics have been established for pulmonary nodules and lung cancer, chronic obstructive pulmonary disease, asthma, snoring disorders and smoking cessation. Through the “Three Famous Projects” and in-depth cooperation with China-Japan Friendship Hospital (the National Center for Integrated Traditional Chinese and Western Medicine Respiratory Medicine), it has established the “Chao Enxiang National Master of Traditional Chinese Medicine, Longjiang School of Medicine, Zhang Hongchun National Famous Traditional Chinese Medicine Physician Academic Inheritance Studio”. Through long-term inheritance and discipline-development guidance from “National Masters of Traditional Chinese Medicine, National Famous Traditional Chinese Medicine Physicians and Qihuang Scholars”, it continuously enhances its clinical diagnostic and treatment capabilities as well as its scientific research innovation and translational capabilities. The department is committed to the traditional Chinese medicine prevention and treatment of epidemic diseases (respiratory viral diseases), leads the formulation and continuous optimization of the “Shenzhen Traditional Chinese Medicine Prevention and Treatment Plan for Novel Coronavirus Pneumonia”, and has developed the innovative drug Guben Qingfei Granules, which has obtained an acceptance number from the National Medical Products Administration. Traditional Chinese medicine is integrated with modern technology; relying on an intelligent data platform, the department achieves full-cycle management of pulmonary rehabilitation and actively builds smart wards using wearable devices. It strengthens the three major traditional Chinese medicine disease categories of “cough, asthma disorder and wheezing syndrome”, and develops three new directions: integrated traditional Chinese and Western medicine precision diagnosis and treatment and whole-course management of pulmonary nodules and lung cancer, full-cycle pulmonary rehabilitation integrating traditional Chinese and Western medicine, and interventional diagnosis and treatment through respiratory endoscopy, providing patients with “precise, minimally invasive and whole-course” diagnostic and treatment services. The department currently has in-house preparations and agreed prescriptions including “Zhike Liyan Granules, Jiawei Chuanbei Pipa Syrup, Fuzheng Sanjie Pills, Huatan Pills and Feixian Pills”, as well as agreed ointment formulas including “Yifei Bushen Paste, Jianpi Huatan Paste and Huatan Dingzhi Paste (Smoking Cessation Paste)”. It also carries out a series of traditional Chinese medicine characteristic therapies, including “autologous blood therapy, traditional Chinese medicine nasal irrigation, Bian-stone moxibustion and auricular acupoint bean pressing”, providing traditional Chinese medicine clinical services for respiratory diseases in a comprehensive, whole-process manner. In the past 5 years, it has obtained 3 National Natural Science Foundation of China projects and multiple provincial- and ministerial-level projects, participated in 3 National Key Research and Development Program projects, and received approved research funding of RMB 10 million. It has received multiple honors including the Science and Technology Award of the China Association of Chinese Medicine. It has published more than 100 academic papers, including more than 10 SCI papers, compiled more than 10 monographs and applied for 4 patents. 【Department Group Photo】